Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00549341 · ClinicalTrials.gov registry record · Phase 1
PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia
A Phase 1 study, sponsored by Mentor Worldwide.
- Completed
- Registry status
- Phase 1
- Development phase
- 70
- Enrollment target
NCT00549341: Completed Phase 1 study, sponsored by Mentor Worldwide.
NCT00549341 is a Phase 1 study that has completed, run by Mentor Worldwide. The registered enrollment target is 70 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00549341, a Phase 1 study, has completed, sponsored by Mentor Worldwide.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
The safety and efficacy of Mentor Purified Toxin, Botulinum Toxin Type A, Purified Neurotoxin, injected intramuscularly into the neck, is being evaluated as a treatment for painful and non-painful spasmodic torticollis/cervical dystonia. It is hypothesized that treatment will decrease symptom severity and will not have any significant side effects.
Interventions
- DRUG Mentor Purified Toxin, Botulinum Toxn Type A, Purified Neurotoxin
- OTHER Physiologic saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2006-05 |
| Est. Completion | 2009-03 |
| Phase | Phase 1 |
What the finished NCT00549341 record still lists
NCT00549341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% higher).
The record links to 0 conditions, and to 2 interventions - of which Mentor Purified Toxin, Botulinum Toxn Type A, Purified Neurotoxin is the first listed.
NCT00549341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00549341 about?
NCT00549341 is a clinical study titled "PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia". The safety and efficacy of Mentor Purified Toxin, Botulinum Toxin Type A, Purified Neurotoxin, injected intramuscularly into the neck, is being evaluated as a treatment for painful and non-painful spasmodic torticollis/cervical dystonia. It is hypothesized that treatment will decrease symptom severi...
What is the current status of trial NCT00549341?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 70 participants. The study started on 2006-05. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00549341?
The interventions under investigation include: Mentor Purified Toxin, Botulinum Toxn Type A, Purified Neurotoxin (DRUG), Physiologic saline (OTHER).
Who is sponsoring clinical trial NCT00549341?
This trial is sponsored by Mentor Worldwide, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00549341's enrollment target sits among peer trials
70 749th of 2000 higher than 1,227 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia